This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Thomas L. Petty, MD

JAMA. 1993;269(21):2785.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

It is well-known that smoking is a major contributor to premature morbidity and mortality from cardiovascular diseases, lung cancer and at least six other cancers, and chronic obstructive pulmonary disease. But what is not commonly known is that pulmonary function impairment is a powerful predictor of patients at risk for premature morbidity and mortality from these smoking-related diseases. A reduced forced vital capacity, forced expiratory volume in 1 second, or both identify patients at increased risk of these smokingrelated disease states compared with patients matched by age, sex, and smoking histories who do not have pulmonary function impairment. Accordingly, simple spirometric measurements are both specific and nonspecific predictors of premature mortality from many causes.

See also p 2741.

More than a century ago, John Hutchinson, MB, a surgeon, invented the spirometer.¹ He offered his device to the insurance industry of London, England, as a potential tool to predict patients . . . [Full Text PDF of this Article]

Author Affiliations
From the PSL Center for Health Sciences Education, Denver, Colo (Dr Petty).

Footnotes
Reprint requests to PSL Center for Health Sciences Education, 1719 E 19th Ave, Denver, CO 80218 (Dr Petty).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?